---
layout: post
title: "Advancing Real-World Evidence Program"
date: 2026-02-05 19:01:12 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-22795
original_published: 2022-10-20 00:00:00 +0000
significance: 8.00
---

# Advancing Real-World Evidence Program

**Published:** February 05, 2026 19:01 UTC
**Source:** Federal Register
**Original Published:** October 20, 2022 00:00 UTC
**Document Number:** 2022-22795

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the Advancing Real-World Evidence (RWE) Program to fulfill FDA's commitment under the seventh iteration of the Prescription Drug User Fee Amendments (PDUFA VII), incorporated as part of the FDA User Fee Reauthorization Act of 2022.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/10/20/2022-22795/advancing-real-world-evidence-program)
- API: https://www.federalregister.gov/api/v1/documents/2022-22795

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
